Fox Run Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,437
| Closed | -$311K | – | 1038 |
|
|
2023
Q1 | $311K | Buy |
13,437
+5,701
| +74% | +$132K | 0.1% | 391 |
|
|
2022
Q4 | $203K | Sell |
7,736
-11,830
| -60% | -$310K | 0.08% | 484 |
|
|
2022
Q3 | $385K | Buy |
+19,566
| New | +$385K | 0.15% | 264 |
|
|
2018
Q3 | – | Sell |
-4,946
| Closed | -$173K | – | 882 |
|
|
2018
Q2 | $173K | Buy |
4,946
+436
| +10% | +$15.3K | 0.05% | 594 |
|
|
2018
Q1 | $210K | Sell |
4,510
-45
| -1% | -$2.1K | 0.05% | 615 |
|
|
2017
Q4 | $171K | Buy |
4,555
+2,175
| +91% | +$81.7K | 0.05% | 597 |
|
|
2017
Q3 | $127K | Buy |
+2,380
| New | +$127K | 0.04% | 635 |
|
|
2017
Q2 | – | Sell |
-3,760
| Closed | -$202K | – | 879 |
|
|
2017
Q1 | $202K | Buy |
+3,760
| New | +$202K | 0.08% | 492 |
|
|
2016
Q4 | – | Sell |
-2,800
| Closed | -$174K | – | 717 |
|
|
2016
Q3 | $174K | Buy |
+2,800
| New | +$174K | 0.1% | 414 |
|